UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Randomized Phase III Trial of Single-Agent Pemetrexed Versus Carboplatin and Pemetrexed in Patients With Advanced Non–Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status of 2

Journal of clinical oncology, 2013-08, Vol.31 (23), p.2849-2853

2013

Volltextzugriff (PDF)

Mitomycin-C– or Cisplatin-Based Chemoradiotherapy for Anal Canal Carcinoma: Long-Term Results

International journal of radiation oncology, biology, physics, 2011-02, Vol.79 (2), p.490-495

2011

Volltextzugriff (PDF)

Influence of Sentinel Lymph Node Tumor Burden on Survival in Melanoma

Annals of surgical oncology, 2010-04, Vol.17 (4), p.1152-1158

2010

Volltextzugriff (PDF)

Long-term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low-level laser therapy (LLLT) to prevent oral mucositis

Oral oncology, 2017-08, Vol.71, p.11-15

2017

Volltextzugriff (PDF)

Phase I Trial of Erlotinib Combined with Cisplatin and Radiotherapy for Patients with Locally Advanced Cervical Squamous Cell Cancer

Clinical cancer research, 2008-10, Vol.14 (19), p.6324-6329

2008

Volltextzugriff (PDF)

Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer

Cancer, 2014-04, Vol.120 (8), p.1187-1193

2014

Volltextzugriff (PDF)

Does the Sequence of Anthracycline and Taxane Matter? The NeoSAMBA Trial

The oncologist (Dayton, Ohio), 2020-09, Vol.25 (9), p.758-764

2020

Volltextzugriff (PDF)

Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation

Radiotherapy and oncology, 2013-11, Vol.109 (2), p.297-302

2013

Volltextzugriff (PDF)

Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation

Oral oncology, 2016-01, Vol.52, p.85-90

2016

Volltextzugriff (PDF)

XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy

Urologic oncology, 2009-07, Vol.27 (4), p.382-390

2009

Volltextzugriff (PDF)

Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma

International Brazilian journal of urology, 2007-10, Vol.33 (5), p.630-638

2007

Volltextzugriff (PDF)

Interferon‐inducible guanylate binding protein (GBP)‐2: A novel p53‐regulated tumor marker in esophageal squamous cell carcinomas

International journal of cancer, 2009-01, Vol.124 (2), p.272-279

2009

Volltextzugriff (PDF)

Impact of Previous Tracheotomy as a Prognostic Factor in Patients with Locally Advanced Squamous Cell Carcinoma of the Larynx Submitted to Concomitant Chemotherapy and Radiation

O.R.L. Journal for oto-rhino-laryngology and its related specialties, 2008-01, Vol.70 (6), p.381-388

2008

Volltextzugriff (PDF)

Phase II Trial of Neoadjuvant Chemotherapy Using Alternating Doublets in Non-Small-Cell Lung Cancer

Clinical lung cancer, 2007, Vol.8 (4), p.257-263

2007

Volltextzugriff (PDF)

Re: Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma

International Brazilian journal of urology, 2007-12, Vol.33 (6), p.840-841

Sherif, Amir

2007

Volltextzugriff (PDF)

Re: Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma

International braz j urol, 2007-12, Vol.33 (6), p.840-841

2007

Volltextzugriff (PDF)

The prognostic role of PD-L1 expression and the presence of polyomavirus in Merkel cell carcinoma cases

Infectious agents and cancer, 2024-01, Vol.19 (1), p.1-1, Article 1

2024

Volltextzugriff (PDF)

Breast cancer brain metastases: The graded prognostic assessment index (GPA) in a real-world low- and middle-income (LMIC) population

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18531-e18531

2023

Volltextzugriff (PDF)

Exploring biomarkers and prognostic factors in uterine carcinosarcoma: An insight into L1CAM, CDX2, p53, and MSI status

PloS one, 2023-05, Vol.18 (5), p.e0285447-e0285447

2023

Volltextzugriff (PDF)

Is there a role for conventional-dose chemotherapy in relapsed germ cell tumors?

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.404-404

2020

Volltextzugriff (PDF)

Neoadjuvant zoledronic acid for HER2-positive breast cancer: the Zo-NAnTax trial

Therapeutic advances in medical oncology, 2019-05, Vol.11, p.1758835919853971

2019

Volltextzugriff (PDF)

Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial

Blood, 2007-03, Vol.109 (5), p.2250-2255

2007

Volltextzugriff (PDF)

Does the sequence of anthracycline and taxane matter? The NeoSAMBA trial

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.575-575

2018

Volltextzugriff (PDF)

Phase II trial of induction chemotherapy plus chemoradiotherapy with aspirin or placebo in high-risk rectal cancer (ICAR)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e16131-e16131

2020

Volltextzugriff (PDF)

Sociodemographic, Clinical, and Pathological Factors Influencing Outcomes in Locally Advanced Triple Negative Breast Cancer: A Brazilian Cohort

Breast cancer : basic and clinical research, 2020, Vol.14, p.1178223420962488-1178223420962488

2020

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(40)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(24)
Female
(23)
Science & Technology
(23)
Life Sciences & Biomedicine
(22)
Middle Aged
(20)
Aged
(17)
Male
(17)
Adult
(16)
Oncology
(16)
Tumors
(13)
Biological And Medical Sciences
(11)
Medical Sciences
(11)
Chemotherapy
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Prospective Studies
(7)
Chemotherapy, Adjuvant
(6)
Cisplatin - Administration & Dosage
(6)
Disease-Free Survival
(6)
Retrospective Studies
(6)
Treatment Outcome
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized Phase III Trial of Single-Agent Pemetrexed Versus Carboplatin and Pemetrexed in Patients With Advanced Non–Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status of 2

Mitomycin-C– or Cisplatin-Based Chemoradiotherapy for Anal Canal Carcinoma: Long-Term Results

Influence of Sentinel Lymph Node Tumor Burden on Survival in Melanoma

Long-term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low-level laser therapy (LLLT) to prevent oral mucositis

Phase I Trial of Erlotinib Combined with Cisplatin and Radiotherapy for Patients with Locally Advanced Cervical Squamous Cell Cancer

Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer

Does the Sequence of Anthracycline and Taxane Matter? The NeoSAMBA Trial

Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation

Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation

XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy

Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma

Interferon‐inducible guanylate binding protein (GBP)‐2: A novel p53‐regulated tumor marker in esophageal squamous cell carcinomas

Impact of Previous Tracheotomy as a Prognostic Factor in Patients with Locally Advanced Squamous Cell Carcinoma of the Larynx Submitted to Concomitant Chemotherapy and Radiation

Phase II Trial of Neoadjuvant Chemotherapy Using Alternating Doublets in Non-Small-Cell Lung Cancer

Re: Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma

Re: Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma

The prognostic role of PD-L1 expression and the presence of polyomavirus in Merkel cell carcinoma cases

Breast cancer brain metastases: The graded prognostic assessment index (GPA) in a real-world low- and middle-income (LMIC) population

Exploring biomarkers and prognostic factors in uterine carcinosarcoma: An insight into L1CAM, CDX2, p53, and MSI status

Is there a role for conventional-dose chemotherapy in relapsed germ cell tumors?

Neoadjuvant zoledronic acid for HER2-positive breast cancer: the Zo-NAnTax trial

Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial

Does the sequence of anthracycline and taxane matter? The NeoSAMBA trial

Phase II trial of induction chemotherapy plus chemoradiotherapy with aspirin or placebo in high-risk rectal cancer (ICAR)

Sociodemographic, Clinical, and Pathological Factors Influencing Outcomes in Locally Advanced Triple Negative Breast Cancer: A Brazilian Cohort

Suchergebnisse filtern